Follow
Joel Shapiro
Joel Shapiro
PhD-candidate, Department of Surgery Erasmus MC
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
J Shapiro, JJB Van Lanschot, MCCM Hulshof, P van Hagen, ...
The lancet oncology 16 (9), 1090-1098, 2015
23072015
Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial
BM Eyck, JJB van Lanschot, MCCM Hulshof, BJ van der Wilk, J Shapiro, ...
Journal of Clinical Oncology 39 (18), 1995-2004, 2021
3612021
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
BJ Noordman, MCW Spaander, R Valkema, BPL Wijnhoven, ...
The Lancet Oncology 19 (7), 965-974, 2018
2362018
Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A
M Pulvino, Y Liang, D Oleksyn, M DeRan, E Van Pelt, J Shapiro, I Sanz, ...
Blood, The Journal of the American Society of Hematology 120 (8), 1668-1677, 2012
1802012
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival
AK Talsma, J Shapiro, CWN Looman, P van Hagen, EW Steyerberg, ...
Annals of surgery 260 (5), 786-793, 2014
1582014
A clinicopathologic study of 42 patients with granulomatous gastritis: is there really an “idiopathic” granulomatous gastritis?
JL Shapiro, JR Goldblum, RE Petras
The American journal of surgical pathology 20 (4), 462-470, 1996
1261996
Encoding of whisker input by cerebellar Purkinje cells
LWJ Bosman, SKE Koekkoek, J Shapiro, BFM Rijken, F Zandstra, ...
The Journal of physiology 588 (19), 3757-3783, 2010
1162010
Sarcopenia/muscle mass is not a prognostic factor for short‐and long‐term outcome after esophagectomy for cancer
BA Grotenhuis, J Shapiro, S Van Adrichem, M de Vries, M Koek, ...
World journal of surgery 40 (11), 2698-2704, 2016
1152016
Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer
J Shapiro, P Van Hagen, HF Lingsma, BPL Wijnhoven, K Biermann, ...
Annals of surgery 260 (5), 807-814, 2014
992014
Accuracy of detecting residual disease after cross neoadjuvant chemoradiotherapy for esophageal cancer (preSANO Trial): rationale and protocol
BJ Noordman, J Shapiro, MCW Spaander, KK Krishnadath, ...
JMIR research protocols 4 (2), e4320, 2015
862015
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma
CAJ Ong, J Shapiro, KS Nason, JM Davison, X Liu, C Ross-Innes, ...
Journal of clinical oncology 31 (12), 1576, 2013
832013
Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa
J Shapiro, FJW ten Kate, P van Hagen, K Biermann, BPL Wijnhoven, ...
Annals of Surgery 258 (5), 678-689, 2013
792013
Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically
JL Frater, KF McCarron, JP Hammel, JL Shapiro, ML Miller, RR Tubbs, ...
American journal of clinical pathology 116 (5), 655-664, 2001
702001
Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial
BJ Noordman, MGE Verdam, SM Lagarde, J Shapiro, M Hulshof, ...
Annals of Oncology 29 (2), 445-451, 2018
692018
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy
A Zeidan, R Sham, J Shapiro, A Baratta, P Kouides
Leukemia & lymphoma 48 (7), 1410-1413, 2007
572007
Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline
M Pulvino, L Chen, D Oleksyn, J Li, G Compitello, R Rossi, S Spence, ...
Oncotarget 6 (17), 14796, 2015
482015
Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer
ELA Toxopeus, D Nieboer, J Shapiro, K Biermann, A van der Gaast, ...
Radiotherapy and Oncology 115 (3), 392-398, 2015
412015
Patients' preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer
BJ Noordman, EW de Bekker-Grob, P Coene, E van der Harst, ...
Journal of British Surgery 105 (12), 1630-1638, 2018
402018
Prognostic value of pretreatment pathological tumor extent in patients treated with neoadjuvant chemoradiotherapy plus surgery for esophageal or junctional cancer
J Shapiro, K Biermann, D van Klaveren, GJA Offerhaus, FJW Ten Kate, ...
Annals of surgery 265 (2), 356-362, 2017
382017
CD5 B-Cell Lymphoproliferative Disorders Presenting in Blood and Bone Marrow: A Clinicopathologic Study of 40 Patients
JL Shapiro, ML Miller, B Pohlman, E Mascha, AJ Fishleder
American journal of clinical pathology 111 (4), 477-487, 1999
351999
The system can't perform the operation now. Try again later.
Articles 1–20